The Economist's recent briefing on a new class of drugs for weight loss provides a compelling overview of the potential breakthroughs that could revolutionize obesity treatment. The article highlights the significant challenges that researchers have faced in developing effective weight-loss drugs and explores the scientific advances that have recently been made. One key development is the discovery of hormones that regulate appetite, such as GLP-1 and PYY, which have been targeted by several new drugs. These medications mimic the effects of natural hormones to help people feel fuller for longer periods and reduce food cravings. Other promising drugs are designed to block the absorption of fat or carbohydrates, while some aim to stimulate the body's metabolism to burn more calories. To read more, use the button below to open the original external article.

Tehnološki napredek s potencialom za izboljšanje zdravja ljudi včasih prihaja z najbolj nepričakovanih krajev. Zanimiv primer je biološka nanožica, ki prevaja električno energijo in obeta napajanje miniaturiziranih srčnih spodbujevalnikov in drugih elektronskih naprav za vsaditev.

Genetic medicine is getting a major tune-up. Recent advancements in genomics, bioinformatics and molecular biology are laying the foundation for a new era in precision genetic medicine - in which cellular and genomic information about disease will be incorporated into clinical care. The...